| Application no. and date | 13158391.6 (espacenet) (Federated) (European Patent Register), 20090310 | | Patent/reg. no. and date | DK/EP 2644204, 20170419 | | Publication date | 20131002 | | Priority no. and date | US 37410 P, 20080318 | | EP pub. no. and date |
EP 2644204 20131002 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco,
CA 94080, US | | Applicant ref. no. | P81503395DK01E | | Inventor | Berry, Leanne, 1088 Crestwood Drive
South San Francisco, CA California 94080, US,
Phillips, Gail, Lewis, 515 Dr Anza Avenue
San Carlos, CA California 94070, US,
Sliwkowski Mark, X., 42 Oak Creek Lane
San Carlos, CA California 94070, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61K 47/50 (2017.01) , A61P 35/00 (2006.01) | | Title | Kombinationer af et anti-HER2-antistof-lægemiddel-konjugat og pertuzumab | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
